Integra Lifesciences Holdings Corp Share Price Today: Live Updates & Key Insights

Integra Lifesciences Holdings Corp share price today is $8.94, up 0.45%. The stock opened at $8.84 against the previous close of $8.9, with an intraday high of $9.125 and low of $8.79.

Integra Lifesciences Holdings Corp Share Price Chart

Integra Lifesciences Holdings Corp

us-stock
To Invest in {{usstockname}}
us-stock

Integra Lifesciences Holdings Corp Share Price Performance

$8.94 0.0045(0.45%) IART at 23 Mar 2026 01:32 PM Medical Devices
Lowest Today 8.79
Highest Today 9.125
Today’s Open 8.84
Prev. Close 8.9
52 Week High 22.96
52 Week Low 8.70
Day’s Range: Low 8.79 High 9.125
52-Week Range: Low 8.70 High 22.96
1 day return -
1 Week return -1.21
1 month return -24.19
3 month return -28.78
6 month return -38.02
1 year return -60.67
3 year return -83.34
5 year return -86.72
10 year return -

Integra Lifesciences Holdings Corp Institutional Holdings

BlackRock Inc 13.12

Rubric Capital Management LP 9.95

Vanguard Group Inc 9.25

iShares Core S&P Small-Cap ETF 5.24

Fuller & Thaler Asset Management Inc 5.02

Morgan Stanley - Brokerage Accounts 4.91

Amvescap Plc. 4.48

FullerThaler Behavioral Small-Cap Value 4.13

Invesco Small Cap Value A 4.02

Dimensional Fund Advisors, Inc. 3.96

Undiscovered Managers Behavioral Val L 3.71

State Street Corp 3.58

Paradigm Capital Management, Inc. 3.42

Vanguard Total Stock Mkt Idx Inv 2.67

Neuberger Berman Group LLC 2.67

Geode Capital Management, LLC 2.16

iShares Russell 2000 ETF 2.12

Charles Schwab Investment Management Inc 2.00

The Goldman Sachs Group Inc 1.97

Vanguard Small Cap Index 1.93

Soleus Capital Management, L.P. 1.85

Wellington Management Company LLP 1.74

J. Goldman & Co LP 1.60

Systematic Financial Management LP 1.42

JPMorgan Chase & Co 1.42

Invenomic Capital Management, LP 1.35

Vanguard Small Cap Value Index Inv 1.24

Glenmede Investment Management, LP 1.08

Schwab Fundamental U.S. Small CompanyETF 1.00

Vanguard Institutional Extnd Mkt Idx Tr 0.94

Glenmede Small Cap Equity 0.90

Glenmede Small Cap Equity Adv 0.90

Invenomic Institutional 0.87

Fidelity Small Cap Index 0.84

iShares S&P Small-Cap 600 Value ETF 0.84

State Street SPDR Port S&P 600 Sm CpETF 0.79

iShares Russell 2000 Value ETF 0.75

Neuberger Intrinsic Value I 0.72

Paradigm Micro-Cap 0.64

PIMCO RAE US Small 0.64

Integra Lifesciences Holdings Corp Market Status

Strong Buy: 2

Buy: 1

Hold: 5

Sell: 2

Strong Sell: 2

Integra Lifesciences Holdings Corp Fundamentals

Market Cap 696.76 M

PB Ratio 0.6681

PE Ratio 0.0

Enterprise Value 2466.59 M

Total Assets 3602.00 M

Volume 1684687

Integra Lifesciences Holdings Corp Company Financials

Annual Revenue FY24:1610527000 1610.5M, FY23:1542556000 1542.6M, FY22:1557666000 1557.7M, FY21:1542448000 1542.4M, FY20:1371868000 1371.9M

Annual Profit FY24:1610527000 1610.5M, FY23:908327000 908.3M, FY22:970311000 970.3M, FY21:944640000 944.6M, FY20:851034000 851.0M

Annual Net worth FY24:-6944000 -6.9M, FY23:100853000 100.9M, FY22:180550000 180.6M, FY21:169075000 169.1M, FY20:133892000 133.9M

Quarterly Revenue Q3/2025:402062000 402.1M, Q2/2025:415605000 415.6M, Q1/2025:382653000 382.7M, Q3/2024:380834000 380.8M, Q2/2024:418175000 418.2M

Quarterly Profit Q3/2025:226108000 226.1M, Q2/2025:209332000 209.3M, Q1/2025:194432000 194.4M, Q3/2024:200238000 200.2M, Q2/2024:232470000 232.5M

Quarterly Net worth Q3/2025:-5404000 -5.4M, Q2/2025:-484073000 -484.1M, Q1/2025:-25293000 -25.3M, Q3/2024:-10695000 -10.7M, Q2/2024:-12402000 -12.4M

About Integra Lifesciences Holdings Corp & investment objective

Company Information Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Organisation Medical Devices

Employees 4427

Industry Medical Devices

CEO Ms. Mojdeh Poul

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Integra Lifesciences Holdings Corp FAQs

What is the share price of Integra Lifesciences Holdings Corp today?

The current share price of Integra Lifesciences Holdings Corp is $8.94.

Can I buy Integra Lifesciences Holdings Corp shares in India?

Yes, Indian investors can buy Integra Lifesciences Holdings Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy Integra Lifesciences Holdings Corp shares in India?

You can easily invest in Integra Lifesciences Holdings Corp shares from India by:

Can I buy fractional shares of Integra Lifesciences Holdings Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Integra Lifesciences Holdings Corp?

Integra Lifesciences Holdings Corp has a market cap of $696.76 M.

In which sector does Integra Lifesciences Holdings Corp belong?

Integra Lifesciences Holdings Corp operates in the Medical Devices sector.

What documents are required to invest in Integra Lifesciences Holdings Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of Integra Lifesciences Holdings Corp?

The PE ratio of Integra Lifesciences Holdings Corp is N/A and the PB ratio is 0.67.